What is Retatrutide?
Retatrutide is a triple-agonist peptide — meaning it activates three different hormone receptors simultaneously: GLP-1, GIP, and glucagon. That triple action is what separates it from earlier generation GLP-1 drugs like semaglutide (Ozempic) or dual-agonists like tirzepatide (Mounjaro).
In Phase 3 clinical trials, retatrutide produced some of the highest weight loss percentages ever recorded in a pharmaceutical trial — averaging around 22-24% body weight reduction over roughly a year. For context, semaglutide averages around 15% and tirzepatide around 20%.
In the Philippines, it's becoming one of the most talked-about compounds in the fitness and aesthetics community — not just for people trying to lose a lot of weight, but for athletes and fitness-focused people using it for body recomposition and fat loss while preserving muscle.
How Does Retatrutide Work?
The three receptors it hits each contribute something different:
GLP-1 slows gastric emptying (you feel full longer), reduces appetite signals in the brain, and improves insulin response.
GIP works alongside GLP-1 to enhance the insulin response and appears to improve fat metabolism directly.
Glucagon increases energy expenditure — meaning your body burns more calories at rest. This is the part that makes retatrutide different from the others. It's not just eating less, it's also burning more.
The combination produces more significant fat loss than any single-receptor approach, which is why the trial numbers look the way they do.
What the Philippines Fitness Community Uses It For
Most people in the local fitness and biohacking community running retatrutide are using it for:
Body recomposition — getting leaner while maintaining or building muscle, especially when combined with resistance training.
Fat loss acceleration — cutting body fat faster than diet and training alone.
Metabolic reset — some people run a shorter cycle to break through a fat loss plateau.
It's worth noting that retatrutide is not just a weight loss drug. At lower doses, it's being used by people who are already lean and just want to get leaner. The appetite suppression at lower doses is manageable, and the metabolic upregulation is the part people are after.
Dosage Overview
Clinical trials used doses ranging from 0.5 mg to 12 mg per week, administered subcutaneously (under the skin), typically once weekly. The fitness community generally runs lower doses than the high-end trial doses.
For a full breakdown of dosage protocols, titration schedules, and what to expect at different doses, see the Retatrutide Dosage Guide.
Side Effects to Know
The most commonly reported side effects are GI-related — nausea, vomiting, and reduced appetite. These are most pronounced when starting or increasing dose. Titrating up slowly is how you manage this.
At higher doses, muscle loss is a real concern if protein intake and resistance training aren't prioritized. This is why the fitness-focused community pairs it with training and high protein intake as non-negotiables.
How to Source Retatrutide in the Philippines
Retatrutide is not available through Philippine pharmacies. It's sourced as a research peptide from overseas suppliers. Cold chain handling during shipping matters — the compound should be kept cold.
See the Vendor Directory for suppliers the community uses. Always verify COAs before purchasing.
Frequently Asked Questions
Is retatrutide FDA approved?
As of early 2026, retatrutide is still in Phase 3 trials and has not received FDA approval. It's available as a research chemical from peptide suppliers.
How does retatrutide compare to semaglutide?
Retatrutide produces greater weight loss than semaglutide in trials, primarily because of the added glucagon receptor activation increasing energy expenditure. See the Retatrutide vs Semaglutide comparison for a full breakdown.
Can I stack retatrutide with other peptides?
Some people stack it with BPC-157 for gut protection given the GI side effects. Combining with other metabolic compounds is generally not recommended without medical supervision.